首页> 外国专利> Shinkikinazorinnoseiho

Shinkikinazorinnoseiho

机译:新时期纳祖林人寿保险

摘要

Cpds. of formula (I) and their acid addn. salts: (where Z is opt. substd. alkylene or monounsatd. alkenylene; both opt. interrupted by is not 2 heteroatoms and both with 4-7 chain members, or Z is opt. substd. diunsatd. alkenylene, opt. interrupted by is not 2 N atoms and contg. 4-6 chain members; and R is alkyl, CF3, alkoxy, halo or H), have antibacterial and antiparasitic action, esp. action against plasmodia (e.g. Plasmodium berghei). They may be used therapeutically or prophylactically) against normal- and chloroquin-resistant strains of malaria. (I) also have blood-pressure decreasing and diuretic activity and are inters. for other materials, esp. pharmaceuticals.
机译:Cpds。式(I)的化合物及其酸加成。盐:(其中Z是亚烷基或单不饱和亚链烯基;两个被opt中断的子代均不大于2个杂原子,且均具有4-7个链元,或者Z是被亚丙基二不饱和亚烯基,被opt中断。不大于2个N原子且不包含4-6个链成员;且R为烷基,CF3,烷氧基,卤素或H),具有抗菌和抗寄生虫作用,尤其是。抗疟原虫(例如伯氏疟原虫)的作用。它们可以在治疗上或预防上用于抵抗疟疾的正常和耐氯喹菌株。 (I)也有降血压和利尿的作用,并且相互影响。对于其他材料,尤其是药品。

著录项

  • 公开/公告号JPS5050390A

    专利类型

  • 公开/公告日1975-05-06

    原文格式PDF

  • 申请/专利权人 CIBA GEIGY;

    申请/专利号JP19740102142

  • 发明设计人 KURISUTEIAN EGURI;KURUTO AIHENBAAGA;

    申请日1974-09-06

  • 分类号C07D239/95;A61K31/395;A61K31/415;A61K31/47;A61K31/495;A61K31/535;C07Dnull/null;C07D401/12;C07D403/12;C07D413/12;

  • 国家 JP

  • 入库时间 2022-08-23 04:48:12

获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号